WALLDORF — SAP SE (NYSE: SAP) today announced the launch of its vaccine collaboration hub (VCH) for organizations to better manage vaccine supply distribution, and to help governments and their industry partners coordinate and successfully deploy mass vaccination programs.
SAP’s VCH is built on the industry-award-winning SAP Information Collaboration Hub for Life Sciences. It covers the end-to-end process from manufacturing to controlled distribution to administration and postvaccine monitoring.
“COVID-19 has put a lot of pressure on the life sciences industry where they have realized a large gap in their supply chain strategy,” said Michael Townsend, industry analyst at IDC. “A one-stop place for the life sciences industry to manage their vaccination procedures and tap into a source of suppliers, even those across industries, will help to fill this gap, to ensure patients obtain lifesaving drugs and devices.”
Businesses that are part of the vaccine production process, from manufacturers, logistics service providers and pharma companies to wholesalers and dispensers, can run their critical vaccine processes on SAP software. Building on its deep expertise in the industry, SAP has designed the VCH as an extension to its business network–enabled drug supply chain, to help make collaboration among the network partners easy and monitor the order fulfillment of vaccines, all the way from vaccine suppliers to the dispensing units.
The VCH provides the critical network and technology capabilities required to effectively support large-scale vaccination programs and drug distribution while creating the backbone to better mitigate future emergencies.
To learn more, read “Shortening the Road to Recovery.”
Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “project,” “predict,” “should” and “will” and similar expressions as they relate to SAP are intended to identify such forward-looking statements. SAP undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. The factors that could affect SAP’s future financial results are discussed more fully in SAP’s filings with the U.S. Securities and Exchange Commission (“SEC”), including SAP’s most recent Annual Report on Form 20-F filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.
© 2020 SAP SE. All rights reserved.
SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE in Germany and other countries. Please see https://www.sap.com/copyright for additional trademark information and notices.